Biological signal measurement device and method for controlling biological
By combining ECG sensors and PPG sensors to obtain ECG signals and pulse wave data, the problem that limb-type electrocardiographs and PPG sensors are difficult to accurately diagnose atrial fibrillation in daily life is solved, and reliable circulatory system disease monitoring and diagnosis is achieved.
Patent Information
- Application Number
- CN202480015870.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-03-15
- Filing Date
- 2024-02-21
- Publication Date
- 2025-10-17
AI Technical Summary
Existing limb-mounted ECG monitors are easily affected by myoelectric noise, which results in a decrease in ECG signal quality and makes it difficult to accurately diagnose atrial fibrillation during activities. PPG sensors cannot accurately distinguish atrial fibrillation from other arrhythmias, making it difficult for existing devices to provide reliable diagnosis of circulatory system diseases in daily life.
Combining ECG sensors and PPG sensors, the information processing unit obtains ECG signals and pulse wave data. The P wave information and heart rate variability of the ECG signal are used, combined with the heart rate variability of the PPG signal, to achieve accurate diagnosis of atrial fibrillation. Dry electrodes and PPG sensors are used for signal measurement.
In daily life, it can reliably monitor and diagnose circulatory system diseases such as atrial fibrillation, improve the reliability and accuracy of data, reduce the impact of myoelectric noise, and realize 24-hour atrial fibrillation monitoring and recording of related indicators.